Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma.

Saved in:
Bibliographic Details
Title: Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma.
Authors: Choi J; Department of Neurosurgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, USA., Medikonda R; Department of Neurosurgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, USA., Saleh L; Department of Neurosurgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, USA., Kim T; Department of Neurosurgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, USA., Pant A; Department of Neurosurgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, USA., Srivastava S; Department of Neurosurgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, USA., Kim YH; Department of Neurosurgery, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea., Jackson C; Department of Neurosurgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, USA., Tong L; Department of Neurosurgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, USA., Routkevitch D; Department of Neurosurgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, USA., Jackson C; Department of Neurosurgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, USA., Mathios D; Department of Neurosurgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, USA., Zhao T; Department of Neurosurgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, USA., Cho H; Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea., Brem H; Department of Neurosurgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, USA., Lim M; Department of Neurosurgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, USA.
Source: Oncoimmunology [Oncoimmunology] 2021 Aug 29; Vol. 10 (1), pp. 1956142. Date of Electronic Publication: 2021 Aug 29 (Print Publication: 2021).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2162-402X
DOI:10.1080/2162402X.2021.1956142